ATH
Click for more information
33.3% 0.4¢ alterity therapeutics limited

PBT434 inhibits alpha- synuclein in the brain., page-13

  1. skint
    5,921 Posts.
    lightbulb Created with Sketch. 151
    clock Created with Sketch.
    05/08/19
    17:00
    Post #: 39867620
    pivalde, I agree the info from the trial leaves room for guesswork. It is interesting that both BIIB and AstraZenica/Takeda are going directly after A-Syn in the very early stages of the disease(Parkinsons), when A-Syn levels are apparently dropping in the CSF(spinal fluid).
    This is still early days with BIIB recruiting phase2 and AZ just starting phase1, but to me it looks like PBT434 has more chance of success, with a wider range of effects, such as those being investigated by the Fairpark2 trial with a related drug. They are not even reporting A-Syn as far as I can see.
    All IMO as a non medical observer.
    ATH Price at posting: 2.7¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS High-grade copper assays continue to impress—resource update coming soon
right-arrow Created with Sketch.
NEWS Significant shallow gold intersections at Tambourah King reveal potential extensions to the lode gold system, with promising RC drill results and more assays pending
right-arrow Created with Sketch.
NEWS High-grade drill results confirm extension at Paddy’s Lodes—reinforcing significant discovery and growth potential at Youanmi Gold Project
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Significant increase in revenue from faster NDIS approvals and launch of new leasing programs
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢ 		Change
0.001(33.3%) 		Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $34 10K

Buyers (Bids)

No. Vol. Price($)
28 17196248 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130790145 27
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.